Seitenbereiche

reLeaph

Medizintechnik/Digital Health 2016

20 million people in the US alone suffer from severe chronic pain.
Caught between the actual pain and the side effects caused by pain medication, these patients are severely impacted in their professional as well as in their private lives.

reLeaph is a wearable medical device that offers an effective alternative to traditional pain management strategies and provides actual comfort by eliminating pain without leading the patients into chemical dependency and without causing any other disruptive side effects.

The reLeaph Pain Cancellation Device utilizes the principle implemented in noise cancellation devices: destructive interference.

reLeaph’s adaptive algorithms are designed to analyze the waveform of a nerve signal, then generate awave that represents the inverted[nbsp][nbsp]phase of the original signal. This inverted[nbsp]wave is then amplified and a transducer creates a[nbsp]signal directly proportional to the amplitude of the original waveform; thereby[nbsp]effectively eliminating the original[nbsp]pain signal.

Gründer:

  • Andreas Peneder
  • Johannes Woeckinger
tech2b_releaph_prototype.png

Facts

CEO
Andreas Peneder
Projektstart: 2016
Branche: Medical Device
Mitarbeiter:innen: -
Märkte: USA
reLeaph
Hafenstrasse 47-51
4020 Linz
Tel: -
WordPress Cookie Plugin by Real Cookie Banner